VV
Vivek Valsaraj
About Vivek Valsaraj
Data last updated:
Vivek Valsaraj is a Whole-Time Director at Piramal Pharma Limited (since 2022) and Director at Abbvie Therapeutics India Private Limited (since 2022). The companies operate in Pharma, Healthcare and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹9,615 Cr; the largest is Piramal Pharma Limited at ₹9,082 Cr (FY 2026). Earlier, Vivek Valsaraj was a Director at Drg Analytics & Insights Private Limited (2019–2020) and Cfo at Piramal Enterprises Limited (2017–2022) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 09 Feb 2022 | 2020 | ₹9,082 Cr (FY 2026) | Active | |
| Director | 22 Feb 2022 | 1994 | ₹533 Cr (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Mar 2019 | 2015 | ₹128 Cr (FY 2025) | Active | |
| Cfo | 01 Dec 2017 | 1947 | ₹10,612 Cr (FY 2025) | Amalgamated | |
| Nominee Director | 16 Aug 2019 | 2007 | ₹1.99 Cr (FY 2025) | Active | |
| Additional Director | 22 Jun 2021 | 1979 | ₹133 Cr (FY 2021) | Amalgamated | |
| Director | 19 Nov 2014 | 2014 | ₹120 Cr (FY 2021) | Amalgamated | |
| Additional Director | 18 Sep 2014 | 2008 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vivek Valsaraj
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Valsaraj
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Valsaraj
Vivek Valsaraj currently holds 2 directorships: Piramal Pharma Limited (Whole-Time Director, since 09 Feb 2022, revenue ₹9,082 Cr (FY 2026)); Abbvie Therapeutics India Private Limited (Director, since 22 Feb 2022, revenue ₹533 Cr (FY 2026)).
Vivek Valsaraj was first appointed on 18 Sep 2014 as Additional Director at Piramal Pharmaceutical Development Services Private Limited. The most recent appointment on record is 22 Feb 2022 at Abbvie Therapeutics India Private Limited.
The 2 current companies of Vivek Valsaraj that report revenue have a combined latest revenue of ₹9,615 Cr: Piramal Pharma Limited ₹9,082 Cr (FY 2026); Abbvie Therapeutics India Private Limited ₹533 Cr (FY 2026).
Vivek Valsaraj held 6 earlier board appointments: Drg Analytics & Insights Private Limited (Director, 13 Mar 2019 to 28 Feb 2020); Piramal Enterprises Limited (Cfo, 01 Dec 2017 to 18 Aug 2022); Searchlight Health Private Limited (Nominee Director, 16 Aug 2019 to 15 Apr 2020); Hemmo Pharmaceuticals Private Limited (Additional Director, 22 Jun 2021 to 26 Nov 2021); Convergence Chemicals Private Limited (Director, from 19 Nov 2014); and 1 more.
The current boards of Vivek Valsaraj's companies include Amit Jain (Piramal Pharma Limited), Amit Soni (Piramal Pharma Limited), Jairaj Manohar Purandare (Piramal Pharma Limited), Maneesh Sharma (Piramal Pharma Limited), Nandini Ajay Piramal (Piramal Pharma Limited), Nathalie Ann Leitch (Piramal Pharma Limited), among others.